CLINICO-EPIDEMIOLOGICAL PROFILE OF PATIENTS PRESENTED WITH BREAST LESIONS: AN INSTITUTIONAL ANALYSIS
Main Article Content
Keywords
Breast Cancer, Fibroadenoma, Breast Lump, Fibrocystic disease, Mastalgia
Abstract
Introduction: One of the most common diseases encountered in outpatient department of general surgery unit are breast lesions. 200,000 cases of breast diseases was diagnosed annually. Pattern of presentation of breast diseases varies region to region and race to race. Mastalgia, lump, nipple discharge and skin lesions are the common mode of presentation. Most common benign lesion is fibraoadenoma and most common pattern of presentation is lump followed by mastalgia. Every breast mass should be biopsied and properly treated.
Aim: To determine the clinical and demographic features of patients with breast lesions.
Methods and Materials: This retrospective observational study was conducted in general surgery and surgical oncology unit 2 of Sheikh Zayed Hospital, Lahore, between January 2022 and April 2023. A non-probability convenience sampling technique was used. Data was collected in the form of age, gender, diagnosis, and pattern of presentation in a pre-defined Performa. All the data was analyzed and presented in the form of frequencies and percentages.
Results: A total of 89 patients were included in this study. The mean age of presentation in benign breast disease was 29.3 years, and in malignant breast disease, it was 45.5 years. 15/89 (16.85%) patients had malignant breast diseases, whereas 74/89 (83.15%) patients had benign breast diseases. The most common cause of breast swelling was fibro-adenoma (21.34%), followed by carcinoma breast (16.85%). The least common cause of breast swelling was ductal ectasia (1.12%), followed by phyllodes tumor (3.37%). The most common presenting clinical feature of benign breast swelling was breast mass (83.78%), followed by pain (60.81%). The least common associated clinical feature of benign breast disease is an axillary lump (6.57%), followed by nipple discharge (9.45%). The most common clinical feature of malignant breast swelling was breast mass (93.33%), followed by axillary lump (53.33%).
Conclusion: Most of the Clinico-epidemiological features of patients with breast lesion are similar with those of previous research. Female is the most common gender presented with breast lesion. The mean age of presentation in benign breast disease was 29.3 years, and in malignant breast disease, it was 45.5 years. Benign diseases are the most common culprit for breast pathology. Fibro-adenomas the most common cause of benign breast lesion. Most common clinical presentation of benign and malignant breast lesion is breast mass.
References
2. Siddiqui M, Kayani N, Pervez S, Aziz S, Muzaffar S, Setna Z, et al. Breast diseases: a histopathological analysis of 3279 cases at a tertiary care center in Pakistan. Journal of Pakistan Medical Association. 2003;53(3):94.
3. Angahar LT. An overview of breast cancer epidemiology, risk factors, pathophysiology, and cancer risks reduction. MOJ Biol Med. 2017;1(4):92-6.
4. Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia‐Pacific Journal of Clinical Oncology. 2017;13(4):289-95.
5. Ayoade BA, Tade AO, Salami BA. Clinical features and pattern of presentation of breast diseases in surgical outpatient clinic of a suburban tertiary hospital in South-West Nigeria. Nigerian Journal of Surgery. 2012;18(1).
6. Stachs A, Stubert J, Reimer T, Hartmann S. Benign breast disease in women. Deutsches Ärzteblatt International. 2019;116(33-34):565.
7. Sasaki J, Geletzke A, Kass RB, Klimberg VS, Copeland III EM, Bland KI. Etiology and management of benign breast disease. The Breast: Elsevier; 2018. p. 79-92. e5.
8. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy. 2019:151-64.
9. Trayes KP, Cokenakes SE. Breast cancer treatment. American family physician. 2021;104(2):171-8.
10. Kim J-Y, Kang D, Nam SJ, Kim SW, Lee JE, Yu JH, et al. Clinical features and outcomes of invasive breast cancer: age-specific analysis of a modern hospital-based registry. Journal of global oncology. 2019;5:1-9.
11. Fan Y, Wang Y, He L, Imani S, Wen Q. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival. ESMO open. 2021;6(4):100232.
12. Kudela E, Samec M, Kubatka P, Nachajova M, Laucekova Z, Liskova A, et al. Breast cancer in young women: status quo and advanced disease management by a predictive, preventive, and personalized approach. Cancers. 2019;11(11):1791.
13. Katsura C, Ogunmwonyi I, Kankam HK, Saha S. Breast cancer: presentation, investigation and management. British Journal of Hospital Medicine. 2022;83(2):1-7.
14. Karim MO, Khan KA, Khan AJ, Javed A, Fazid S, Aslam MI. Triple assessment of breast lump: Should we perform core biopsy for every patient? Cureus. 2020;12(3).
15. Hovda T, Tsuruda K, Hoff SR, Sahlberg KK, Hofvind S. Radiological review of prior screening mammograms of screen-detected breast cancer. European radiology. 2021;31:2568-79.
16. Swadi FM. ASSESSMENT OF SPECIFICITY AND SENSITIVITY OF TRU-CUT BIOPSY AS COMPARED WITH POSTOPERATIVE HISTOPATHOLOGICAL RESULTS IN YOUNG FEMALES WITH BREAST MASS. Intl J. 2022;2(4):14-21.
17. Russo J, Russo I, editors. Role of hormones in human breast development: the menopausal breast. Progress in the Management of the Menopause: Proceedings of the 8th International Congress on the Menopause, Sydney, Australia; 2020: CRC Press.
18. Tonape TP, Tulsian AR, Gope DD, Gogineni JC. A study of clinical patterns in benign breast disorders. International Surgery Journal. 2018;5(2):518-22.
19. Gupta A, Gupta AK, Goyal R, Sharma K. A study of clinical profile of benign breast diseases presenting at a tertiary care centre in central India. Scholar J Appl Med Sci. 2015;3(2C):695-700.
20. Kumar N, Prasad J. Epidemiology of benign breast lumps, is it changing: a prospective study. International Surgery Journal. 2019;6(2):465-9.
21. Nair N, Shet T, Parmar V, Havaldar R, Gupta S, Budrukkar A, et al. Breast cancer in a tertiary cancer center in India-An audit, with outcome analysis. Indian journal of cancer. 2018;55(1):16-22.
22. Suresh P, Batra U, Doval D. Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India. Indian Journal of Medical and Paediatric Oncology. 2013;34(02):89-95.
23. Goyal SK, Choudhary D, Beniwal S, Kapoor P, Goyal P. Retrospective analysis of breast lumps in a given population: An institutional study. International Surgery Journal. 2016;3(3):1547-50.
24. Jain SB, Jain I, Shrivastav J, Jain B. A clinicopathological study of breast lumps in patients presenting in surgery OPD in a referral hospital in Madhya Pradesh, India. Int J Current Microbiol App Sci. 2015;4(8):919-23.
25. Shoeb MFR, Pinate AR, Shingade PP. Breast cancer, Clinical presentations, Risk factors, Staging. International Surgery Journal. 2017;4(2):645-9.